https://www.zacks.com/stock/news/2256335/medifast-s-med-transformation-on-track-amid-macro-headwinds?cid=CS-ZC-FT-analyst_blog|rank_focused-2256335
Apr 16, 2024 - Medifast (MED) adapts to shifting consumer behavior to maintain its relevance. However, it is facing difficulties in attracting customers due to the rapidly changing economy and inflation.
zc:6924656187191286897
0
https://www.startribune.com/med-tech-device-manufacturing-life-sciences-commercial-real-estate-office-building-medtronic-boston-scientific/600358022/
Apr 11, 2024 - While office buildings from the suburbs to downtown Minneapolis struggle for survival, construction on more buildings in the life sciences sector is increasing, adding hundreds of thousands of square feet of labs, production space and research facilities to the Twin Cities.
0
sb:5070096447711891815
0
https://www.zacks.com/stock/news/2229533/medifast-med-q4-earnings-beat-estimates-revenues-dip-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2229533
Feb 21, 2024 - Medifast's (MED) Q4 results reflect the impacts of poor customer acquisition. However, it is showing resilience, banking on its strategic focus on medically supported weight loss, indicating potential for growth.
zc:-863351757147104658
0
https://seekingalpha.com/news/4060266-vertex-pharma-stock-gains-non-opioid-pain-therapy?source=feed_sector_healthcare
Jan 30, 2024 - Vertex Pharmaceuticals (VRTX) stock gains as the company's non-opioid pain therapy VX-548 generated positive results in Phase 3 trials. Read more here.
0
sa:-2212512364495635425
0
https://seekingalpha.com/news/4060009-inspira-technologies-up-7-enters-agreement-with-glo-med-for-distribution-in-gulf?source=feed_tag_israel
Jan 30, 2024 - Inspira Technologies (IINN) signs a strategic distribution agreement with Glo-Med Networks to enter the Gulf states, including Saudi Arabia, UAE, and...
0
sa:-6920977875282850204
0
https://seekingalpha.com/news/4056663-glp-1s-can-expand-market-weight-loss-surgery-bernstein?source=feed_sector_healthcare
Jan 21, 2024 - The rising popularity of GLP-1 weight loss medications could expand the market for weight loss surgeries in the long run, according to Bernstein. Read more here.
0
sa:-7896436353859988405
0
https://www.zacks.com/stock/news/2202087/medifast-s-med-holistic-health-solution-innovation-bode-well?cid=CS-ZC-FT-analyst_blog|rank_focused-2202087
Dec 26, 2023 - Medifast's (MED) focus on combining lifestyle coaching with innovative health solutions and targeting diverse markets bode well amid challenges in customer acquisition and high costs.
zc:2531918727364548665
0
https://www.zacks.com/stock/news/2194657/here-s-how-much-you-d-have-if-you-invested-1000-in-medifast-a-decade-ago?cid=CS-ZC-FT-tale_of_the_tape|investing_$1000-2194657
Dec 07, 2023 - Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
zc:-3305566724251390152
0